Selective enrichment of Th1 CD45RBlow CD4+ T cells in autoimmune infiltrates in experimental allergic encephalomyelitis
- PMID: 7910482
- DOI: 10.1093/intimm/6.3.347
Selective enrichment of Th1 CD45RBlow CD4+ T cells in autoimmune infiltrates in experimental allergic encephalomyelitis
Abstract
The cytokine effector status of CD4+ T cells from lymph nodes (LN) and the central nervous system (CNS) of SJL/J mice immunized with autoantigen in adjuvant for the induction of experimental allergic encephalomyelitis (EAE) was compared. CD4+ T cells were FACS sorted based on the levels of expression of the activation marker CD45RB. Low levels of expression of this surface marker are induced by antigen recognition and are associated with 'effector' T cell function. Reverse transcriptase polymerase chain reaction (PCR) was used to analyze the expression of different T cell cytokine genes in the sorted populations. CD45RBlow cells constituted a minority of CD4+ cells in the LN and expressed elevated levels of IL-2, IFN-gamma, and IL-4 mRNA, whereas the CD45RBlow CD4+ population did not express detectable message for these cytokines under linear PCR conditions. By contrast to the LN, CD4+ cells from the CNS were predominantly CD45RBlow and expressed readily detectable levels of IL-2 and IFN-gamma mRNA, but almost no IL-4 transcription could be detected. IL-4 mRNA levels in CNS were 100- to 250-fold lower than in LN. Also, IL-4 message could not be detected in the CNS 1 week after remission. A cytokine-specific immunocytochemical single cell staining technique was used to enumerate cytokine-producing cells in LN cell populations and in CNS infiltrates. Between 1 and 5% cells in isolated LN cells produced detectable IL-2 and IFN-gamma. By contrast, the frequency of cytokine-producing cells stained in perivascular infiltrates in frozen sections from the brains of animals with active EAE was 10-fold higher.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines.J Immunol. 1995 Jan 15;154(2):944-53. J Immunol. 1995. PMID: 7814894
-
The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis.Eur J Immunol. 1997 Nov;27(11):2840-7. doi: 10.1002/eji.1830271115. Eur J Immunol. 1997. PMID: 9394808
-
Direct demonstration of the infiltration of murine central nervous system by Pgp-1/CD44high CD45RB(low) CD4+ T cells that induce experimental allergic encephalomyelitis.J Neuroimmunol. 1992 Sep;40(1):57-69. doi: 10.1016/0165-5728(92)90213-5. J Neuroimmunol. 1992. PMID: 1381382
-
Cytokines in the induction and resolution of experimental autoimmune encephalomyelitis.Cytokine. 2005 Oct 21;32(2):81-4. doi: 10.1016/j.cyto.2005.07.012. Epub 2005 Sep 8. Cytokine. 2005. PMID: 16153854 Review.
-
The case against epitope spread in experimental allergic encephalomyelitis.Immunol Rev. 1998 Aug;164:101-10. doi: 10.1111/j.1600-065x.1998.tb01212.x. Immunol Rev. 1998. PMID: 9795768 Review.
Cited by
-
Multiple Sclerosis and Obesity: Possible Roles of Adipokines.Mediators Inflamm. 2016;2016:4036232. doi: 10.1155/2016/4036232. Epub 2016 Sep 18. Mediators Inflamm. 2016. PMID: 27721574 Free PMC article. Review.
-
Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS.J Neurosci. 2003 Aug 27;23(21):7922-30. doi: 10.1523/JNEUROSCI.23-21-07922.2003. J Neurosci. 2003. PMID: 12944523 Free PMC article.
-
Cytokine control of inflammation and repair in the pathology of multiple sclerosis.Yale J Biol Med. 2012 Dec;85(4):447-68. Epub 2012 Dec 13. Yale J Biol Med. 2012. PMID: 23239947 Free PMC article. Review.
-
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation.Nat Med. 2007 Oct;13(10):1173-5. doi: 10.1038/nm1651. Epub 2007 Sep 9. Nat Med. 2007. PMID: 17828272 Free PMC article.
-
Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination.Biomedicines. 2022 Feb 24;10(3):539. doi: 10.3390/biomedicines10030539. Biomedicines. 2022. PMID: 35327341 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials